T38.6
T38.6: Poisoning by, adverse effect of and underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified
Non-billable headerICD-10-CM
T38.6 is a non-billable header ICD-10-CM code for poisoning by, adverse effect of and underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified. It cannot be billed on its own: choose one of the more specific child codes below. This code also requires a 7th character before it is complete.
This code requires a 7th character
The appropriate 7th character is to be added to each code from category T38
- A
- initial encounter
- D
- subsequent encounter
- S
- sequela
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Poisoning by, adverse effect of and underdosing of tamoxifen
Excludes1 inherited from the categories above T38.6
A category’s note binds every code beneath it.
Other codes that can never be billed with T38.6
Their own Excludes1 notes name this code, so the conflict is not listed above.
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Code history
Unchanged in every release from FY2024 to FY2027.
Code to one of these instead T38.6
1 child code. Green means billable.
Other codes under T38
- T38.0Poisoning by, adverse effect of and underdosing of glucocorticoids and synthetic analogues
- T38.1Poisoning by, adverse effect of and underdosing of thyroid hormones and substitutes
- T38.2Poisoning by, adverse effect of and underdosing of antithyroid drugs
- T38.3Poisoning by, adverse effect of and underdosing of insulin and oral hypoglycemic [antidiabetic] drugs
- T38.4Poisoning by, adverse effect of and underdosing of oral contraceptives
- T38.5Poisoning by, adverse effect of and underdosing of other estrogens and progestogens
- T38.7Poisoning by, adverse effect of and underdosing of androgens and anabolic congeners
- T38.8Poisoning by, adverse effect of and underdosing of other and unspecified hormones and synthetic substitutes
- T38.9Poisoning by, adverse effect of and underdosing of other and unspecified hormone antagonists